A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations.
Junfeng WangXavier PouwelsBram RamaekersGeert FrederixChris van LieshoutRudolf HoogenveenXinyu LiG Ardine de WitManuela JooreHendrik KoffijbergAnoukh van GiessenSaskia KniesTalitha L Feenstranull nullPublished in: PharmacoEconomics (2024)
MUDMs would improve on current decision support regarding cost-effectiveness information. Given feasibility challenges, this would be most relevant for diseases with multiple treatments, large burden of disease and requiring more complex models. The current overview offers policy makers a starting point to organize the development, use, and maintenance of MUDMs and to support choices concerning which diseases and policy decisions they will be helpful for.